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atrogenic Pericardial Effusion and Tamponade
n the Percutaneous Intracardiac Intervention Era
avid R. Holmes JR, MD,* Rick Nishimura, MD,* Rebecca Fountain, RN,*
oltan G. Turi, MD†
ochester, Minnesota; and Camden, New Jersey
he number, speciﬁc type, and complexity of percutaneous intracardiac procedures continue to evolve.
any of these procedures require left atrial access using transseptal techniques. These approaches
arry with them the potential for pericardial effusion (PE) and cardiac tamponade, particularly in the
etting when intraprocedural anticoagulation is being administered. PEs and even cardiac tamponade
ave been documented with both diagnostic as well as therapeutic procedures. When the effusion is a
omplication of an intracardiac procedure, it is usually the result of a cardiac perforation. The presenta-
ion depends on several factors including the structure that is perforated, the device that caused the
erforation, the baseline hemodynamic status of the patient, and the level of anticoagulation present.
he incidence has varied substantially although it has been recorded with essentially all intracardiac
rocedures, both diagnostic and therapeutic on both the right and left side of the heart. Prompt rec-
gnition is essential so that prevention of the transition from effusion to tamponade can be attempted
e.g., by reversing anticoagulation) or the hemodynamic collapse can either be averted or treated. Clin-
cal, radiologic, and echocardiographic assessment are each important. Pericardiocentesis can be life-
aving and is a core competency for all laboratories performing invasive cardiac procedures. Systems
f care must include the knowledge base, equipment, and expert echocardiographic and interventional
ersonnel. Collaboration with noninvasive colleagues and training interventionalists who perform intra-
ardiac interventions, both electrophysiologists and interventional cardiologists, should be required as
art of every invasive program. (J Am Coll Cardiol Intv 2009;2:705–17) © 2009 by the American
ollege of Cardiology Foundationr
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ahe number and complexity of percutaneous in-
racardiac procedures continues to increase as a
ariety of new technologies for structural heart
isease and electrophysiology interventions are in-
roduced. Many of these procedures have in com-
on the need for intraprocedural anticoagulation,
nd a number require transseptal puncture. As a
rom the *Mayo Clinic, Rochester, Minnesota; and the †Robert Wood
ohnson Medical School, Cooper Vascular Center, Cooper University
ospital, Camden, New Jersey. Sotirios Tsimikas, MD, served as Guest
ditor for this paper.canuscript received March 12, 2009, accepted April 3, 2009.esult, they all carry a risk of pericardial effusion
PE) and tamponade. The procedures include clo-
ure of patent foramen ovale, atrial and ventricular
eptal defects; percutaneous heart valve repair,
alloon dilation or percutaneous valve replacement;
nd left atrial (LA) appendage occlusion. In the
lectrophysiology setting, an increased risk for
ffusion is associated with left-sided arrhythmia
blations, placement of biventricular pacemakers,
nd implantable cardioverter-defibrillators. This
rticle reviews the presentation, frequency, timing,
nd outcome of PE and tamponade as a compli-
ation of intracardiac interventions.
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706emodynamics of Tamponade
he pericardium consists of a visceral and parietal segment
hat extends from the lower third of the superior vena cava
o the apex of the heart (1,2). The parietal pericardium is
ormally 2 mm thick and is composed of collagen and
lastin; it is relatively noncompliant and acts to limit
brupt expansion of the heart in response to a variety of
oading conditions. Normally, a small amount of fluid is
resent ranging in volume from 20 to 50 cc; this may
ause a slight separation between the 2 pericardial sur-
aces, typically not more than 5 mm.
The response of the pericardium to fluid accumulation
as been well described (2– 4). The compliance of the
arietal pericardium increases slowly, although it can
ventually accommodate large volumes; 500 cc or more
ay be tolerated without any hemodynamic compromise
hen accumulation occurs over weeks to months (Fig.
A). However, in the setting of percutaneous interven-
ion, fluid accumulation is abrupt and as little as 100 cc
ay result in hemodynamic decompensation (3,4). The
noncompliant pericardium has
a steep pressure volume curve
(Fig. 1B); as intrapericardial
pressure rises, the transmural
pressure results in collapse of
the right atrium (RA) first, fol-
lowed by collapse of the right
ventricle (RV) during progres-
sively longer portions of dias-
tole (Fig. 2). Compression of
left-sided chambers usually oc-
curs in severe tamponade or, in
ome cases, when loculation affects a discrete portion of
he left heart only. Another pathophysiological mecha-
ism may relate to lack of LA and left ventricular (LV)
lling. There is a continuum of clinical manifestations
hat depends upon the speed of accumulation and the
bsolute volume that accumulates as well as the underly-
ng presence or absence of associated cardiac disease
2– 4); this variability ranges from early echocardio-
raphic manifestations of right-sided chamber compres-
ion to shock and hemodynamic collapse.
When PE is a complication of an intracardiac proce-
ure, the effusion is usually the result of a perforation and
ay develop rapidly. The perforation may be caused by a
uidewire, dilator, sheath, balloon or guiding catheter,
acemaker lead, or excessive ablation energy. The pre-
entation depends in part on at least 5 factors: the size of
he device responsible for the perforation; the structure
hat is perforated, such as atrial versus ventricular myo-
ardium, RA or LA, RV or LV; the hemodynamic state
bbreviations
nd Acronyms
E  pericardial effusion
A  left atrial/atrium
V  left ventricle/
entricular
A  right atrial/atrium
V  right ventricle/
entriculart the time of perforation; properties of the pericardium atself; and the coagulation status. Full anticoagulation in
articular is a major risk factor for both PE and its
equelae. After cardiac surgery, the pericardium may be
bsent or adherent to the myocardial reflection and may
revent the development of tamponade, although this is
ot the case universally because tamponade and hemo-
ynamic compromise can result from a posterior localized
ffusion (and may be particularly difficult to reach during
Figure 1. Pericardium and Pressure Volume Curves
(A) The pericardium surrounding the heart in a normal physiologic setting
and in tamponade. The pericardium can be seen to extend to the proximal
great vessels. Note the large amount of effusion in the image on the right,
which is consistent with chronic pericardial stretch and leading more
slowly to tamponade than would normally be the case in iatrogenic perfo-
rations. Courtesy Mayo Foundation for Medical Education. (B) Pressure vol-
ume curve of normal pericardium (left) and compliant pericardium (right).
In the setting of rapid onset of effusion in the normal pericardium, low vol-
umes, typically rising from a range beginning lower than 50 cc and rising
to some unspeciﬁed point, lead to a rise in pressure that exceeds the limit
of pericardial stretch, with early onset of tamponade physiology. More
compliant pericardium, a result of chronic stretching, does not result in
critical extramural pressures until substantially higher volumes, in some
cases more than a liter. Reprinted, with permission, Turi (66). RA  right
atrial.ttempted pericardiocentesis).
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707The pressure within the structure that is perforated is
major determinant of the development and severity of
amponade. Thus a small perforation of the RV in an
nanticoagulated patient may not be clinically apparent;
n contrast, perforation of the RV in the setting of
ulmonary hypertension or anticoagulation can be cata-
trophic. These same considerations apply for both the
A and LA as well.
The specific chamber involved is very important in
etermining not only presentation but also outcome. The
V typically has a transmural thickness of 4 mm and
lacement of temporary and permanent pacemakers as well
s electrophysiology catheters is associated with a small but
ignificant perforation rate, the frequency of which is
robably underestimated because of lack of clinical sequelae
n many unanticoagulated patients. The thicker wall of the
V (10 mm) may act to seal small perforations, balancing
he higher intrachamber pressures. However, even a small
uidewire perforation may not be tolerated if it occurs in
atients with resistance to LV outflow, such as in severe
ortic stenosis. In this case, very high LV pressure and high
fterload result in the newly created hole in the chamber
cting as a “pop-off” valve, with blood preferentially driven
oward an initially low pressure intrapericardial space. The
ossibility of tamponade is substantially increased, as was
een with early experiences of aortic valvuloplasty (5), for
hich a 1.8% rate of tamponade was reported in 492
atients, and caused by guidewire, catheter, or balloon
erforation. In contrast, a small RA perforation may be well
olerated in some patients not on anticoagulants because of
Figure 2. Pericardial Tamponade With Right-Sided Collapse
Echocardiographic image showing pericardial tamponade with right-sided
collapse. Reprinted, with permission, from Priscilla Peters, Cooper University
Hospital, Camden, New Jersey. Eff  effusion; LA  left atrium; LV  left
ventricle; RA  right atrium; RV  right ventricle.ow intracardiac pressures and therefore low driving pres- aure. Perforation of the LA is potentially much more
erious, primarily because procedures involving the LA are
lways associated with anticoagulation, and because LA
ressure is typically higher than RA pressure. Finally, the
eometry of the perforation may also be important. A
litlike perforation may result in different patterns of fluid
ccumulation than a circular hole, particularly if the wall of
he affected chamber is thin.
ecognition of PE and Tamponade
linical. The occurrence of myocardial perforation and sub-
equent fluid accumulation within the pericardium should
e suspected clinically during the time of catheterization if
he patient begins to complain of chest pain. The typical
ain of a new pericardial irritation is that of substernal
iscomfort sometimes radiating up into the neck and jaw.
cute pericardial irritation can also present with atypical
ymptoms such as shoulder discomfort, abdominal discom-
ort, or even nausea. In some instances, the patient may
escribe a sense of doom even before hemodynamic changes
re observed.
Central aortic pressure and RA pressures can provide
xcellent indirect evidence of perforation and subsequent
amponade. In the very early stages, the blood pressure
esponse is variable: although hypotension is a hallmark of
amponade, systemic aortic pressure may actually increase
nitially along with an increase in heart rate due to a
ympathetic response to the initial pericardial irritation. On
ccasion, the earliest finding is acute bradycardia and
ypotension, reflecting a vasovagal reaction to sudden peri-
ardial stretch. Other symptoms may include nausea or
hest discomfort. As tamponade begins to develop, systemic
ressure may be sustained transiently by increased adrener-
ic stimulation and peripheral vasoconstriction. However,
ulse pressure will decrease and pulsus paradoxus develop
eflecting an exaggerated decrease in pulse pressure during
nspiration. At this time, RV filling pressures will begin to
levate. The contour of the RA pressure will subsequently
hange during early stages of tamponade. There will be a
oss of the y descent and in patients who remain in sinus
hythm, and there will be a more prominent a wave at the
ime of atrial contraction (Figs. 3A and 3B). As pericardial
amponade develops, there will then be a significant de-
rease in aortic systolic pressure and rise in RA pressure
Fig. 4). The pulse pressure may be so narrow during
nspiration that the observer will be unable to detect
ndividual heart beats (Fig. 5). Straightening and immobil-
ty of the left heart border on fluoroscopy is a reliable
djunctive marker of tamponade in the catheterization
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708aboratory and occurs concomitantly with significant hemo-
ynamic deterioration. Intervention is indicated in the early
emodynamic stages, once there is a noticeable pulsus
aradoxus, even in the absence of a drop in overall systemic
ressure.
Chest radiography may be helpful in some settings (6,7).
ypically, large effusions present as globular cardiology with
harp margins, sometimes referred to as a “water bottle”
ilhouette. If the effusion develops during catheterization, it
ay also be identified by the development of lucent lines in
he cardiopericardial silhouette—the so-called epicardial
alo sign or fat pad sign.
Figure 3. Pericardial Tamponade
(Left) Very early signs of pericardial tamponade. Although the aortic pressure
rapid y descent (arrow). This indicates that pericardial effusion has already sta
and vasoconstriction allows the aortic pressure (Ao) to remain elevated. (Right
pulse pressure and a relative tachycardia. However, pulsus paradoxus is not ye
Figure 4. Classic Pericardial Tamponade
The RA pressure is severely elevated. Most of the increase in pressure occurs a
and pulse pressure have signiﬁcantly fallen. During inspiration (Insp), there is a
classic pulsus paradoxus. Abbreviations as in Figure 3.chocardiography. Echocardiography should be per-
ormed as soon as there is a suspicion of PE or tampon-
de, such as with onset of chest discomfort after trans-
eptal puncture, even in the absence of hemodynamic
bnormalities, because early diagnosis of tamponade
hould prompt the operator to discontinue the interven-
ion and if appropriate, reverse the anticoagulation. In
any instances, there may not be a large PE but rather a
mall circumferential effusion that was not present before
he procedure. Although not all patients will have had a
aseline echocardiogram, many patients have that as part
f their diagnostic cardiac workup. In addition, in many
t fallen, there is a mild elevation of right atrial (RA) pressure and loss of the
cause problems ﬁlling the ventricle. The increased sympathetic discharge
he amount of pericardial effusion progresses, there will be a decrease in
ent.
onset of atrial contraction and there is both loss of x and y descent. The Ao
er drop in pulse pressure than during expiration (Exp). This demonstrateshas no
rted to
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709enters, pre-procedural echocardiography is an integral
art of procedural planning, such as LA appendage
bliteration or mitral valve dilation. Loculated PEs may
lso be seen, primarily in the posterior region of the
ericardium (Fig. 6). The typical 2-dimensional echocar-
iographic findings of RV collapse and right atrial
nvagination may not be seen in the early stages of
amponade, because they require transmural pressures
reater than the intracardiac chamber pressures; thus
hese findings may also not be present or may be delayed
n patients who have specific forms of underlying heart
isease where intracardiac chamber pressures are ele-
ated. This may be particularly the case in patients with
V hypertrophy where pericardial fluid may not result in
nitial RA and RV diastolic collapse. One of the most
ensitive methods for detecting early pericardial tampon-
de is the finding of a new septal shift on 2-dimensional
chocardiography, indicating ventricular interdepen-
ence. Pulse-wave Doppler interrogation of the mitral
nflow velocity is also important to detect early subclinical
tages of tamponade, with dissociation of intrathoracic
nd intracardiac pressures as well as enhancement of
Figure 5. Pulsus Paradoxus as Reflected on Systemic Pressure at 100-mm
Pulse pressure is obliterated during inspiration (red arrows). Reprinted, with pentricular interaction. This will result in a decrease in ghe initial E velocity during inspiration on the transmitral
ow velocity curve. In typical tamponade, there is an
verall decrease in the E:A ratio, due to a low early
iastolic filling (Fig. 7). However, the initial E velocity
ill decrease further with inspiration due to decreased
lling in the left side countered by increased filling of the
ight side during inspiration. One caveat must be kept in
ind. Echocardiography initially universally documents a
ree space. However, as anticoagulation is stopped in a
pecific patient or if coagulation of the pericardial fluid
tarts, the free space may not be as visible. Careful
nalysis of the images and hemodynamic monitoring can
dentify and resolve this issue.
ransseptal Puncture
fter its initial introduction (8) for diagnostic assessment
f left heart pressures, transseptal catheterization nearly
isappeared from the catheterization laboratory arma-
entarium (9) as indirect measurement of LA pressure
y the pulmonary arterial wedge technique and retro-
cale
sion, from Turi (66).Hg Srade LV catheterization were introduced. The last 2
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710ecades have seen a rebirth of interest in transseptal left
eart catheterization, occasioned primarily by LA struc-
ural and electrophysiologic interventions. A survey of
ospitals in Italy showed a 60-fold increase in transseptal
unctures by electrophysiologists alone between 1992 and
003 (10) (Fig. 8).
Ross (11) recently reviewed the origins and develop-
ent of the technique. In 1962, the Clinical Center at
he National Institute of Health published the first 450
ases and reported no procedure-related mortality; sub-
equently in 1966, Ross (12) reported on 350 additional
atients. At that time, relative contraindications to trans-
eptal puncture included anticoagulation, LA thrombus,
nd anatomic abnormalities such as severe kyphoscoliosis
r marked dilation of the ascending aorta. Some of these
elative contraindications remain operative. The learning
urve for transseptal procedures particularly when struc-
ural heart disease is present can be steep (13). Use of
chocardiographic guidance has added a measure of
afety to the operator learning curve (14) and allows for
afer puncture in settings of anatomic deformity as well.
Figure 6. Still Frame of a 2-Dimensional Echocardiogram From a Patient
With Pericardial Tamponade Occurring During a Catheter Intervention
There is a localized pericardial effusion (PE), which is all posterior. There is
compression of the left ventricle. The right ventricle has invagination dur-
ing diastole. The posterior location of the PE would necessitate an entry for
pericardiocentesis from a modiﬁed apical window. Abbreviations as in
Figure 2.t also allows more accurate determination of transseptal aeedle location in the fossa ovalis as opposed to the more
uscular atrial septum; although entry into the LA
hrough the latter is adequate for many purposes, passage
f devices across the septum and manipulation of cathe-
ers through a thickened, sometimes calcified septal wall
ay seriously impair performance of some procedures. In
ontrast, some interventions, such as percutaneous mitral
alve repair, may benefit from higher entry (15) and
thers, such as the percutaneous metal mitral valvulotome
echnique (16), required a relatively low puncture.
Transseptal puncture has been an important source of
E and tamponade in procedures requiring LA access
ven in a primarily diagnostic catheterization setting: a
eview of 278 transseptal punctures revealed a 3.2%
ncidence of pericardial puncture with incipient or clini-
ally significant tamponade (17). In general there has
een a growing base of experienced operators in the past
ecade. In addition, newer techniques (18 –21), such as
omputed tomography guidance, radiofrequency, and
aser-facilitated puncture are being developed along with
echnology for safer access via the jugular vein.
ffusion and Tamponade as a
unction of Specific Procedures
he specific incidence of PE complicating intracardiac
rocedures varies depending on the procedure. Some of
hese procedures are diagnostic procedures such as myocar-
ial biopsies or transseptal catheterization for assessment of
ortic stenosis. However, they also occur with therapeutic
rocedures such as ablations, mitral or aortic valve dilation,
r LA appendage occlusion devices. In general, mild to
oderate effusions occur several times more frequently than
amponade. The latter ranges from 1% to 6% in most
eries depending on the technique for assessment, level of
nticoagulation, and type of procedure among other factors.
n reviewing the statistics that follow, it is important to note
hat most of the studies described did not prospectively
creen for PE; thus small to moderate effusions, late
ffusions, and those that did not produce significant symp-
oms or hemodynamic compromise could have been missed
n many of these series. To evaluate the exact incidence,
tudies would need to perform serial echocardiograms pro-
ressively screening from a pre-procedure baseline through
ost-hospital discharge follow-up. In the absence of such
rotocols, the overall numbers in many series may represent
small percentage of the actual effusions that occurred. An
mportant additional reason that the incidence of effusion is
nderestimated is the timing. Although the effusion typi-
ally develops during the procedure, it may occur days later,
articularly if the patient is subsequently placed on antico-
gulant or intensive antiplatelet therapy (22,23).
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711trial Fibrillation Ablation
blation of left-sided pathways is a technically demanding
nd frequently prolonged procedure, requiring transseptal
uncture and extensive catheter manipulation, prolonged
nticoagulation, and multiple energy deliveries into the wall
f the heart. Complications include pulmonary vein steno-
is, esophageal injury, thromboembolism, phrenic nerve
Figure 7. Transmitral Doppler Velocity Curves
Transmitral Doppler velocity curves (showing the E and A waves) with simulta
with pericardial tamponade. During inspiration there is a marked decrease in t
pressures seen in pericardial disease. Abbreviations as in Figure 2.
Figure 8. Growth of Transseptal Puncture Over a DecadeThe growth of transseptal puncture over a decade of electrophysiology procedures injury, and a significant incidence of tamponade (24). In
007, the Heart Rhythm Society, European Heart Rhythm
ssociation, and the European Cardiac Arrhythmia Society
ublished an expert consensus statement on ablation for
trial fibrillation (25). This document described cardiac
amponade occurring in up to 6% of procedures and
dentified it as the most common potentially life-
hreatening complication associated with this procedure.
left ventricular and pulmonary artery wedge pressures (PAWP) in patient
tial E velocity. This is due to a dissociation of intracardiac and intrathoracicneous
he inin 33 hospitals in Italy. Reprinted, with permission, from De Ponti et al. (10).
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712he specific type and power of the ablation protocol
ontributes to tamponade risk (26). The sites of perforation
nclude the RA, roof or free wall of the LA, and the LA
ppendage. Bunch et al. (27), reviewed 632 procedures
erformed from January 1999 to October 2004, 2.4% of
hich were complicated by perforation requiring pericar-
iocentesis. The most common site of perforation was the
A (60%), followed by the RV (33%), and the RA (6.7%).
ll were initially managed with pericardiocentesis, but 13%
ubsequently required surgery because of persistent bleed-
ng. Of importance is the fact that in 90% of the patients,
outine use of intracardiac echocardiography documented an
ffusion before the onset of overt hemodynamic instability.
ecently, Fagundes et al. (28) reported on 1,150 consecutive
atients undergoing single transseptal punctures in antici-
ation of atrial fibrillation ablation. In this series, which
nrolled patients from 2003 to 2005, a PE was documented
n 2.7% and tamponade requiring pericardiocentesis in 1%.
Other recent series include a worldwide survey of atrial
brillation ablation that reported an incidence of tamponade
rom 1% to 3% (29). The variability in reported incidence
ay result from several factors including different ablation
nergy strategies, routine use of intracardiac ultrasound, and
perator learning curve. The incidence of effusion not
esulting in tamponade is likely several times higher; detec-
ion in this setting depends upon how often routine echo-
ardiographic screening is performed.
acemakers
he incidence of cardiac perforation with permanent pace-
aker implantation also varies widely. Mahapatra et al. (30)
valuated 4,280 permanent pacemakers implanted from
995 to 2003 and found an incidence of suspected perfora-
ion within 7 days of the procedure in 1.7%. Of 50 patients
ith chest pain or hypotension without known prior effu-
ion, tamponade physiology was demonstrated by echo in
0%, 83% of whom had hypotension; 70% required peri-
ardiocentesis. Multivariate predictors of perforation in-
luded use of a temporary pacemaker, helical active fixation
eads, and steroids. In a similar type of analysis, Navarrete et
l. (31) reported on their experience of cardiac tamponade
equiring pericardiocentesis or surgical drainage from 1985
o 2002 and found that 5.4% of these cases were related to
acemaker implantation. Danik et al. (32) reported an
ncidence of 3.8% with a specific implantable cardioverter-
efibrillator lead, 40% of whom required pericardiocentesis.
he time course is occasionally significantly delayed (33),
ncluding reports of tamponade occurring 30 days after
mplantation (22).
The etiology of the perforation varies in this setting. PE
ay result from attempts to position a lead in the tributaries tf the coronary sinus or during attempted removal of failed
eads. As previously mentioned, the apex of the RV is often
ery thin walled, particularly in older women. Placement of
permanent or a temporary pacemaker may result in PE or
amponade even without adjunctive anticoagulation. Tech-
iques to prevent this include the use of biplane fluoroscopy
r echo to ensure that the lead is placed against the septum
nstead of at the free wall. Small 3-F temporary “screw-in”
eads can aid in avoiding perforation with temporary pace-
aker insertion.
ercutaneous Mitral Valvuloplasty
his procedure began the modern structural heart disease
ntervention era. It is associated with up to 4% risk of
amponade, a level reported in both a 146-patient series
rom the Beth Israel Hospital in Boston (34) and the
38-patient National Heart, Lungs, and Blood Institute
itral Valvuloplasty Registry (35) (Table 1 [36–45]). The
auses of tamponade are multifactorial, including transseptal
uncture, and, in the era of single or double cylindrical
alloon use, rare but catastrophic “harpooning” of a balloon
hrough the apex of the LV. Catheter and sheath manipu-
ation in the LA were culprits as well. A review of 10 cases
f tamponade from a series of 903 mitral valvuloplasty
atients (43) demonstrated the following mechanisms: per-
oration during transseptal puncture (2 cases), harpooning
f the LV apex (3 cases), apical guidewire perforations (2
ases), stitch perforation of the RA caused by low transsep-
al puncture with fenestration of the posterior RA wall (2
ases), and temporary pacing catheter-induced RV perfora-
Table 1. Percutaneous Balloon Mitral Valvuloplasty: Examples of
Incidence of Tamponade in 1 Type of Structural Heart Disease
Intervention
Author(s) (Ref. #) No. of Patients Death (%) Tamponade (%)
Vahanian et al. (37) 200 0 0.5
Ruiz et al. (38) 285 1.1 2.1
Hung et al. (39) 219 0.5 0
Cohen et al. (34) 146 1.4 4.1
Rothlisberger et al. (40) 235 0.8 1.3
NHLBI (35) 738 1.0 4.0
Feldman (41) 290 1.4 1.4
Arora et al. (42) 600 1.0 1.3
Joseph et al. (43) 903 0.9 1.1
Bozat et al. (44)* 243 0.0 1.5
Varma et al. (45) 1,388 0.2 0.6
*Comparison of percutaneous balloon mitral valvuloplasty in unanticoagulated (n  109) and
anticoagulated patients (n  134). Tamponade occurred only in the anticoagulated patients.
Adapted, with permission, from Glazier and Turi (36).ion (1 case). The investigators demonstrated an inverse
r
e
v
s
b
L
T
t
L
c
r
m
a
6
(
t
d
P
c
i
e
p
2
t
e
d
a
t
a
P
M
T
s
p
E
a
P
P
p
o
(
d
r
p
t
f
c
o
t
D
t
a
(
a
i
p
P
T
r
s
c
t
i
i
r
c
t
a
t
t
P
P
c
e
c
d
(
f
D
f
a
r
o
a
o
w
p
u
w
J A C C : C A R D I O V A S C U L A R I N T E R V E N T I O N S , V O L . 2 , N O . 8 , 2 0 0 9 Holmes Jr. et al.
A U G U S T 2 0 0 9 : 7 0 5 – 1 7 Iatrogenic Pericardial Effusion
713elationship between incidence of tamponade and operator
xperience. The percutaneous metal commissurotomy de-
ice designed by Cribier et al. (16) caused tamponade
econdary to trauma from a stiff guidewire and rigid metal
ulb designed to exert traction on the metal valvulotome.
A Appendage Occlusion
his procedure involves placement of a nitinol frame struc-
ure with a polyester membrane and fixation barbs inside the
A appendage. The device is designed to be partially
ompressed and to be held in place by a combination of
adial force and the fixation barbs that protrude approxi-
ately 1 mm into the wall of the appendage. The LA
ppendage itself can be extremely thin-walled. In the initial
6-patient pilot experience with the Watchman device
Atritech, Plymouth, Minnesota), there were 2 cases of
amponade (3.0%) and 3 additional effusions that were
escribed as minor (46). The use of a predecessor device,
LAATO (Percutaneous Left Atrial Appendage Trans-
atheter Occlusion) (Appriva Medical Inc., Sunnyvale, Cal-
fornia), made of a nitinol cage with a polytetrafluoroethyl-
ne fabric and 3 rows of fixation barbs was associated with
ericardiocentesis in 2 cases of tamponade (1.8%) and 1 of
nontamponade effusions in a 111-patient series; in addi-
ion 1 hemothorax occurred (47). With increasing operator
xperience, manipulation of the delivery sheath and occluder
evice inside the appendage has become more atraumatic; in
ddition both the sheath and occluder have been modified
o minimize trauma to the appendage. These maneuvers
nd approaches have appeared to decrease the frequency of
Es.
iscellaneous
here are an increasing number of other therapeutic inva-
ive cardiac procedures. Many of these involve transseptal
uncture or entry into the LA via a patent foramen ovale.
ach of these has the potential to have PE and tamponade
s complications.
ercutaneous Patent Foramen Ovale Closure
ercutaneous closure of patent foramen ovales has been
erformed with increased frequency—both for prevention
f stroke and more recently treatment of recurrent migraine
48–53). The specific frequency of PE or tamponade is
ifficult to ascertain from the literature. In a systematic
eview of the literature, which included 10 studies and 1,355
atients, Khairy et al. (48) classified major complications of ohe procedure as death, hemorrhage requiring blood trans-
usion, massive pulmonary emboli surgical intervention, and
ardiac tamponade as major events, which occurred in 1.5%
f cases.
A number of other procedures require transseptal punc-
ure. These include LV assist using the TandemHeart
evice (Cardiac Assist, Pittsburgh, Pennsylvania) and pros-
hetic mitral paravalvular leak closure. Both have been
ssociated with tamponade although reports are anecdotal
54). Early reports of complications after percutaneous
ortic valve replacement via the transseptal technique have
ncluded up to a 7.4% incidence of mortality related to
eriprocedural tamponade (55).
ercutaneous Valve Repair and Replacement
here is burgeoning interest in the percutaneous repair or
eplacement of valves—both mitral regurgitation and aortic
tenosis. Both procedures have the potential to result in the
omplication of PE. For each of these procedures, although
he number of patients is increasing, there is limited
nformation on that specific complication. The pathophys-
ology of the PE varies. With percutaneous mitral valve
epair, a transseptal approach is required unless only a
oronary sinus approach is used. As is true with any
ransseptal procedure, a PE is possible. With percutaneous
ortic valve replacement using a retrograde aortic approach,
he guidewires used a pre-valve replacement balloon dilation
hat may result in perforation of the LV (56,57).
ercutaneous Coronary Intervention
Es have also been reported as a result of percutaneous
oronary interventions (58 – 63). These are infrequent
vents. Shirakabe et al. (61) evaluated 3,415 percutaneous
oronary intervention procedures between 1991 and 2005,
uring which time, perforation occurred in 12 cases
0.35%). Javaid et al. (62) evaluated a 9-year period and
ound 72 cases (0.19%). These occurred in several settings.
uring the time when directional atherectomy was used
requently, excessive tissue removal was the cause. It may
lso be seen with other atheroablative approaches such as
otational atherectomy, particularly as a result of treatment
f angulated lesions with guidewire bias. Perforation may
lso occur in the setting of treatment of chronic total
cclusions using either antegrade or retrograde approaches
ith a variety of special guidewires. Guidewire coronary
erforation in this setting may be a benign event and may be
nder-reported unless a balloon is inflated in the tract; in
hich case, tamponade may ensue. The definitive treatment
f coronary perforations is different than with perforations
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714f a cardiac chamber. With coronary perforations, a variety
f approaches are possible including prolonged balloon
nflation in addition to reversing anticoagulation, covered
tents if the artery is large enough to accommodate these
evices, or embolization for small vessels. If tamponade
evelops as a result of these perforations, obviously that
ust be treated urgently when definitive percutaneous
reatment of the coronary perforation is undertaken.
ericardiocentesis
arly diagnosis and prompt treatment of PEs with pericar-
iocentesis is life-saving and should be a core competency
or all laboratories performing invasive cardiac procedures
64–66). Systems of care must include knowledge base,
quipment, and expert echocardiographic and interventional
ersonnel. All catheterization laboratories should have a
ericardial puncture “tray set-up” and standard operating
rocedures. In 1 of the largest series of pericardiocenteses,
sang et al. (64) evaluated clinical profile, practice patterns,
nd outcomes in 1,127 therapeutic echocardiograph-guided
ericardiocenteses on 977 patients over a 21-year period. Of
atients undergoing pericardiocentesis, 30% had echocar-
iographic evidence of tamponade physiology, 44% had
vidence of clinical tamponade, and 10% had evidence of
emodynamic collapse; the remaining 16% had evidence of
ffusions without tamponade physiology.
The treatment of iatrogenic PE varies. Typically, when a
ew effusion is documented, the procedure should be
erminated and any anticoagulation should be reversed. In
ome patients, when only a small effusion is present, these 2
aneuvers are sufficient to prevent hemodynamic deterio-
ation. At the other end of the spectrum is tamponade
equiring urgent resuscitation with pericardiocentesis and
lacement of an indwelling catheter for continued evacua-
ion. If there has been a tear in a cardiac structure,
ercutaneous drainage may not successfully resolve the
roblem and, although infrequently, surgery may be
equired.
Using ultrasound guidance, the optimal window for
ericardiocentesis can be determined; in many instances, the
pical and not the subcostal approach is superior. This is
articularly true in acute tamponade, where most of the
ffusion is best visualized from an apical window on the
osterior portion of the pericardium, necessitating an apical
ntry with the needle directed posteriorly. In some in-
tances, a subcostal or lower parasternal approach is best if
he effusion cannot be reached via an apical approach. In
eneral, the specific route for needle placement should be
hat route that provides the shortest and easiest access to the
ericardial space. If a subxyphoid approach is used, care
hould be taken to avoid trauma to the left lobe of the liver. cor intercostal approaches, care must be taken to place the
eedle superior to the specific rib margin to avoid damage to
he intercostal areas. Adequate local anesthesia is important.
ome operators insert a long sheathed 16- to 18-gauge
eedle, whereas others prefer a micropuncture approach.
imited aspiration throughout the insertion of the needle
ith a 20-cc syringe is useful. Once blood is withdrawn
hrough the needle, agitated saline should be injected under
chocardiographic guidance to ensure that the entry point is
ithin the pericardium and not within the ventricular
hambers. Once the entry has been identified, the sheath is
dvanced into the pericardial space. Alternatively, a guide-
ire is inserted into the pericardium under fluoroscopy (to
nsure that there is free flotation of the wire and that the
ourse is consistent with extracardiac insertion and posi-
ion). With either technique, a pigtail catheter is inserted
nd connected to continuous negative pressure. In certain
ituations, a “cell saver” can be used so that the blood drawn
rom the pericardial space can be reinfused back into the
atient.
Although echo-directed pericardiocentesis is optimal, the
rocedure should not be delayed if an echo machine is not
vailable and hemodynamic collapse is imminent. Straight-
ning and immobility of the left heart border, especially if
obility was confirmed to be normal before transseptal
uncture, is usually pathognomonic for tamponade. If the
atient is rapidly deteriorating, a “blind” pericardiocentesis
rom a subcostal approach should be attempted by an
xperienced operator rather than waiting for echocardiog-
aphy during hemodynamic collapse. Intubation should be
voided if at all possible, because the increased transthoracic
ressure may lead to cardiac arrest (65). Temporizing
edical therapy is controversial: rapid infusion of fluids is
dvocated by most operators, although the hemodynamic
enefits have been called into question because rapid volume
nfusion indirectly increases intrapericardial pressure. Intra-
enous nitroprusside to reduce afterload and/or dobutamine
ay also be of benefit in some patients until a pericardio-
entesis can be performed (Figs. 9A and 9B).
onclusions
Es and tamponade remain an important source of com-
lications associated with a wide variety of structural heart
isease and electrophysiologic interventions. Because of the
rowing number and types of these procedures, and the
ignificant learning curves involved, establishing optimal
raining programs in transseptal puncture and in catheter
anipulation in the LA will be important. Collaboration
ith noninvasive colleagues and training interventionalists
ho perform intracardiac interventions to interpret echo-ardiograms should be a part of every invasive program.
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715arly detection of PE before onset of hemodynamic man-
festations and prompt pericardiocentesis may prevent fur-
her complications in many patients. The utility of the
ver-increasing number of intracardiac interventions will
ikely continue to offset the associated risks, even as the risks
ill likely decrease with increasing operator experience and
mproving technology.
eprint requests and correspondence: Dr. David R. Holmes, Jr.,
ayo Clinic, 200 First Street SW, SMH MB 4-523, Rochester,
innesota 55905. E-mail: holmes.david@mayo.edu.
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